AFFY Financials: Affymax Inc AI Analysis

Home

Stock

AFFY

Financials

AFFY Financial

Affymax Inc

At close: Mar 24, 16:00:00 GMT-4

Post-market: Mar 24, 18:09:57 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$0.001

Open

$0.001

Day's Range

$0.001 - $0.001

52 week range

$0.0001 - $0.003

Volume

1.0K

Avg.Volume

15.8K

Dividend yield

EPS (TTM)

0.07

Market Cap

$37.4K

What is AFFY?

Affymax, Inc. is a biopharmaceutical company. The company is headquartered in New York City, New York and currently employs 4 full-time employees. The company went IPO on 2006-12-15. The Company’s product OMONTYS (peginesatide) is for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent (ESA), designed to stimulate production of red blood cells. The firm has a collaboration to develop and commercialize peginesatide with Takeda Pharmaceutical Company Limited. In March 2012, the Food and Drug Administration (FDA) approved the Company’s product, OMONTYS.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

AFFY Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2013	12/31/2012	12/31/2011	12/31/2010	12/31/2009
Revenue	0	1	94	47	112	114
Revenue Growth (YoY)	-100%	-99%	100%	-57.99%	-2%	39%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	5	27	89	32	33	36
Research & Development	0	11	51	76	93	157
Operating Expenses	5	39	141	109	126	193
Other Non Operating Income (Expenses)	8	0	0	0	0	0
Pretax Income	2	-16	-93	-61	-14	-77
Income Tax Expense	0	-2	0	0	0	-1
Net Income	2	-14	-93	-61	-14	-76
Net Income Growth	-102%	-85%	52%	336%	-82%	-12%
Shares Outstanding (Diluted)	37.49	37.44	36.34	33.28	24.48	18.86
Shares Change (YoY)	0%	3%	9%	36%	30%	24%
EPS (Diluted)	0.07	-0.38	-2.57	-1.84	-0.57	-4.05
EPS Growth	-103%	-85%	39%	221%	-86%	-28.99%
Free Cash Flow	-8	-67	-41	-73	-49	-81
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	-3,800%	-50%	-129.78%	-12.5%	-68.42%
Profit Margin	0%	-1,400%	-98.93%	-129.78%	-12.5%	-66.66%
Free Cash Flow Margin	0%	-6,700%	-43.61%	-155.31%	-43.75%	-71.05%
EBITDA	-5	-38	-46	-59	-12	-76
EBITDA Margin	0%	-3,800%	-48.93%	-125.53%	-10.71%	-66.66%
D&A For EBITDA	0	0	1	2	2	2
EBIT	-5	-38	-47	-61	-14	-78
EBIT Margin	0%	-3,800%	-50%	-129.78%	-12.5%	-68.42%
Effective Tax Rate	0%	12.5%	0%	0%	0%	1.29%

Follow-Up Questions

What are Affymax Inc's key financial statements?



According to the latest financial statement (Form-10K), Affymax Inc has a total asset of $7, Net loss of $-14

What are the key financial ratios for AFFY?



Affymax Inc's Current ratio is 0.87, has a Net margin is -1,400, sales per share of $0.02.

How is Affymax Inc's revenue broken down by segment or geography?



Affymax Inc largest revenue segment is Unmanned Aerial Vehicle Propulsion Systems and Flight Critical Components, at a revenue of 9,110,000 in the most earnings release.For geography, Australia is the primary market for Affymax Inc, at a revenue of 12,664,000.

Is Affymax Inc profitable?



no, according to the latest financial statements, Affymax Inc has a net loss of $-14

Does Affymax Inc have any liabilities?



yes, Affymax Inc has liability of 8

How many outstanding shares for Affymax Inc?



Affymax Inc has a total outstanding shares of 37.49

Affymax Inc (AFFY) Financial

AFFY Stock Price Chart